Korean red ginseng saponin fraction downregulates proinfl ammatory mediators in LPS stimulated RAW264.7 cells and protects mice against endotoxic shock

Journal of Ginseng Research

Volumn 36, Issue 3, 2012, Pages 263-269

  Yayeh, Taddessee ^a   Jung, Kun Ho ^b   Jeong, Hye Yoon ^c   Park, Ji Hoon ^a   Song, Yong Bum ^d   Kwak, Yi Seong ^d   Kang, Heun Soo ^e   Cho, Jae Youl ^c   Oh, Jae Wook ^f   Kim, Sang Keun ^b   Rhee, Man Hee ^a  

^a Kyungpook National University   (South Korea)

^b Chungnam National University   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d Ginseng Corporation Central Research Institute   (South Korea)

^e Metabolab Inc   (South Korea)

^f Konkuk University   (South Korea)

Author keywords

20(S) protopanaxadiol saponins; Endotoxic shock; Macrophages; Panax ginseng; Pro inflammatory cytokines

Indexed keywords

MURINAE; MUS; PANAX GINSENG;

EID: 84866327320     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.5142/jgr.2012.36.3.263     Document Type: Article

References (27)

1. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-3064.
2. Laskin DL, Pendino KJ. Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol 1995;35:655-677.
3. Thanawastien A, Montor WR, Labaer J, Mekalanos JJ, Yoon SS. Vibrio cholerae proteome-wide screen for immunostimulatory proteins identifies phosphatidylserine decarboxylase as a novel Toll-like receptor 4 agonist. PLoS Pathog 2009;5:e1000556.
4. Gallucci S, Provenzano C, Mazzarelli P, Scuderi F, Bartoccioni E. Myoblasts produce IL-6 in response to inflammatory stimuli. Int Immunol 1998;10:267-273.
5. Klein RD, Su GL, Aminlari A, Alarcon WH, Wang SC. Pulmonary LPS-binding protein (LBP) upregulation following LPS-mediated injury. J Surg Res 1998;78:42-47.
6. Lee YB, Nagai A, Kim SU. Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res 2002;69:94-103.
7. Cho JY, Park SC, Kim TW, Kim KS, Song JC, Kim SK, Lee HM, Sung HJ, Park HJ, Song YB et al. Radical scavenging and anti-inflammatory activity of extracts from Opuntia humifusa Raf. J Pharm Pharmacol 2006;58:113-119.
8. Imboden JB. The immunopathogenesis of rheumatoid arthritis. Annu Rev Pathol 2009;4:417-434.
9. Chen S. Natural products triggering biological targets: a review of the anti-infl ammatory phytochemicals targeting the arachidonic acid pathway in allergy asthma and rheumatoid arthritis. Curr Drug Targets 2011;12:288-301.
10. Jia L, Zhao Y, Liang XJ. Current evaluation of the millennium phytomedicine-ginseng (II): collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine. Curr Med Chem 2009;16:2924-2942.
11. Kim SK, Park JH. Trends in ginseng research in 2010. J Ginseng Res 2011;35:389-398.
12. Gillis CN. Panax ginseng pharmacology: a nitric oxide link? Biochem Pharmacol 1997;54:1-8.
13. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58:1685-1693.
14. Kim S, Shim S, Choi DS, Kim JH, Kwon YB, Kwon J. Modulation of LPS-stimulated astroglial activation by ginseng total saponins. J Ginseng Res 2011;35:80-85.
15. Yuan CS, Wang CZ, Wicks SM, Qi LW. Chemical and pharmacological studies of saponins with a focus on American ginseng. J Ginseng Res 2010;34:160-167.
16. Ng F, Yun H, Lei X, Danishefsky SJ, Fahey J, Stephenson K, Flexner C, Lee L. (3R, 9R, 10R)-panaxytriol: a molecular-based nutraceutical with possible application to cancer prevention and treatment. Tetrahedron Lett 2008;49:7178-7179.
17. Oh GS, Pae HO, Choi BM, Seo EA, Kim DH, Shin MK, Kim JD, Kim JB, Chung HT. 20(S)-Protopanaxatriol, one of ginsenoside metabolites, inhibits inducible nitric oxide synthase and cyclooxygenase-2 expressions through inactivation of nuclear factor-kappa B in RAW 264.7 macrophages stimulated with lipopolysaccharide. Cancer Lett 2004;205:23-29.
18. Yayeh T, Oh WJ, Park SC, Kim TH, Cho JY, Park HJ, Lee IK, Kim SK, Hong SB, Yun BS et al. Phellinus baumii ethyl acetate extract inhibits lipopolysaccharide-induced iNOS, COX-2, and proinflammatory cytokine expression in RAW264.7 cells. J Nat Med 2012;66:49-54.
19. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315-424.
20. Franco L, Talamini G. Cross-talk between inducible nitric oxide synthase and cyclooxygenase in Helicobacter-pylori-induced gastritis. Med Princ Pract 2009;18:477-481.
21. Milella M, Metro G, Gelibter A, Pino SM, Cognetti F, Fabi A. COX-2 targeting in cancer: a new beginning? Ann Oncol 2008;19:1209-1210.
22. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454:436-444.
23. Cha YI, DuBois RN. NSAIDs and cancer prevention: targets downstream of COX-2. Annu Rev Med 2007;58:239-252.
24. Kim AJ, Kang SJ, Lee KH, Lee M, Ha SD, Cha YS, Kim SY. The chemopreventive potential and anti-inflammatory activities of Korean black ginseng in colon26-M3.1 carcinoma cells and macrophages. J Korean Soc Appl Biol Chem 2010;53:101-105.
25. Kim HS, Kim DH, Kim BK, Yoon SK, Kim MH, Lee JY, Kim HO, Park YM. Effects of topically applied Korean red ginseng and its genuine constituents on atopic dermatitis-like skin lesions in NC/Nga mice. Int Immunopharmacol 2011;11:280-285.
26. Kim SN, Ha YW, Shin H, Son SH, Wu SJ, Kim YS. Simultaneous quantification of 14 ginsenosides in Panax ginseng C.A. Meyer (Korean red ginseng) by HPLCELSD and its application to quality control. J Pharm Biomed Anal 2007;45:164-170.
27. Kim S, Shim S, Choi DS, Kim JH, Kwon YB, Kwon J. Modulation of LPS-Stimulated Astroglial Activation by Ginseng Total Saponins. J Ginseng Res 2011;35:80-85.